{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:35:37Z","timestamp":1769103337360,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T00:00:00Z","timestamp":1472169600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10554-016-0958-1","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T15:31:59Z","timestamp":1472225519000},"page":"1725-1733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients"],"prefix":"10.1007","volume":"32","author":[{"given":"Da-Jun","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Nan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,26]]},"reference":[{"key":"958_CR1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/ERP-14-0115","volume":"2","author":"N Smith","year":"2015","unstructured":"Smith N, Steeds R, Masani N et al (2015) A systematic approach to echocardiography in hypertrophic cardiomyopathy: a guideline protocol from the british society of echocardiography. Echo Res Pract 2:G1\u2013G7. doi: 10.1530\/ERP-14-0115","journal-title":"Echo Res Pract"},{"key":"958_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10554-012-0107-4","volume":"29","author":"R Khan","year":"2013","unstructured":"Khan R, Massel D, Stirrat J et al (2013) Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study. Int J Cardiovasc Imaging 29:395\u2013404. doi: 10.1007\/s10554-012-0107-4","journal-title":"Int J Cardiovasc Imaging"},{"key":"958_CR3","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 113:1807\u20131816. doi: 10.1161\/CIRCULATIONAHA.106.174287","journal-title":"Circulation"},{"key":"958_CR4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1053\/hupa.2000.16659","volume":"31","author":"C Basso","year":"2000","unstructured":"Basso C, Thiene G, Corrado D et al (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31:988\u2013998. doi: 10.1053\/hupa.2000.16659","journal-title":"Hum Pathol"},{"key":"958_CR5","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/CIRCULATIONAHA.104.500546","volume":"111","author":"DL Mann","year":"2005","unstructured":"Mann DL, Bristow MR (2005) Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111:2837\u20132849. doi: 10.1161\/CIRCULATIONAHA.104.500546","journal-title":"Circulation"},{"key":"958_CR6","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/CIRCIMAGING.113.000438","volume":"6","author":"PG Masci","year":"2013","unstructured":"Masci PG, Schuurman R, Andrea B et al (2013) Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging 6:790\u2013799. doi: 10.1161\/CIRCIMAGING.113.000438","journal-title":"Circ Cardiovasc Imaging"},{"key":"958_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.amjcard.2010.03.020","volume":"106","author":"I Olivotto","year":"2010","unstructured":"Olivotto I, Maron BJ, Appelbaum E et al (2010) Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol 106:261\u2013267. doi: 10.1016\/j.amjcard.2010.03.020","journal-title":"Am J Cardiol"},{"key":"958_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0735-1097(98)00184-3","volume":"32","author":"TJ Wu","year":"1998","unstructured":"Wu TJ, Ong JJ, Hwang C et al (1998) Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J Am Coll Cardiol 32:187\u2013196","journal-title":"J Am Coll Cardiol"},{"key":"958_CR9","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/01.CIR.98.22.2404","volume":"98","author":"SM Pogwizd","year":"1998","unstructured":"Pogwizd SM, McKenzie JP, Cain ME (1998) Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation 98:2404\u20132414","journal-title":"Circulation"},{"key":"958_CR10","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.hrthm.2014.01.014","volume":"11","author":"M Perazzolo Marra","year":"2014","unstructured":"Perazzolo Marra M, De Lazzari M, Zorzi A et al (2014) Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. Heart Rhythm 11:856\u2013863. doi: 10.1016\/j.hrthm.2014.01.014","journal-title":"Heart Rhythm"},{"issue":"71\u201395","key":"958_CR11","doi-asserted-by":"publisher","first-page":"vi","DOI":"10.1016\/j.ccl.2007.02.003","volume":"25","author":"JA White","year":"2007","unstructured":"White JA, Patel MR (2007) The role of cardiovascular mri in heart failure and the cardiomyopathies. Cardiol Clin 25(71\u201395):vi. doi: 10.1016\/j.ccl.2007.02.003","journal-title":"Cardiol Clin"},{"key":"958_CR12","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.ijcard.2012.04.064","volume":"167","author":"MS Ahn","year":"2013","unstructured":"Ahn MS, Kim JB, Joung B et al (2013) Prognostic implications of fragmented qrs and its relationship with delayed contrast-enhanced cardiovascular magnetic resonance imaging in patients with non-ischemic dilated cardiomyopathy. Int J Cardiol 167:1417\u20131422. doi: 10.1016\/j.ijcard.2012.04.064","journal-title":"Int J Cardiol"},{"key":"958_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","volume":"57","author":"N Mewton","year":"2011","unstructured":"Mewton N, Liu CY, Croisille P et al (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891\u2013903. doi: 10.1016\/j.jacc.2010.11.013","journal-title":"J Am Coll Cardiol"},{"key":"958_CR14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","volume":"56","author":"O Bruder","year":"2010","unstructured":"Bruder O, Wagner A, Jensen CJ et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56:875\u2013887. doi: 10.1016\/j.jacc.2010.05.007","journal-title":"J Am Coll Cardiol"},{"key":"958_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcard.2010.11.005","volume":"157","author":"PG Masci","year":"2012","unstructured":"Masci PG, Barison A, Aquaro GD et al (2012) Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy. Int J Cardiol 157:43\u201347. doi: 10.1016\/j.ijcard.2010.11.005","journal-title":"Int J Cardiol"},{"key":"958_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/hrt.2010.205542","volume":"97","author":"S Lehrke","year":"2011","unstructured":"Lehrke S, Lossnitzer D, Schob M et al (2011) Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 97:727\u2013732. doi: 10.1136\/hrt.2010.205542","journal-title":"Heart"},{"key":"958_CR17","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","volume":"51","author":"KC Wu","year":"2008","unstructured":"Wu KC, Weiss RG, Thiemann DR et al (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51:2414\u20132421. doi: 10.1016\/j.jacc.2008.03.018","journal-title":"J Am Coll Cardiol"},{"key":"958_CR18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","volume":"48","author":"RG Assomull","year":"2006","unstructured":"Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977\u20131985. doi: 10.1016\/j.jacc.2006.07.049","journal-title":"J Am Coll Cardiol"},{"key":"958_CR19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s001470100339","volume":"14","author":"N Leeuw de","year":"2001","unstructured":"de Leeuw N, Ruiter DJ, Balk AH et al (2001) Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 14:299\u2013306","journal-title":"Transpl Int"},{"key":"958_CR20","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","volume":"110","author":"UC Sharma","year":"2004","unstructured":"Sharma UC, Pokharel S, van Brakel TJ et al (2004) Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110:3121\u20133128. doi: 10.1161\/01.CIR.0000147181.65298.4D","journal-title":"Circulation"},{"key":"958_CR21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/CIRCHEARTFAILURE.112.000146","volume":"6","author":"RA Weir","year":"2013","unstructured":"Weir RA, Petrie CJ, Murphy CA et al (2013) Galectin-3 and cardiac function in survivors of acute myocardial infarction. Circ Heart Fail 6:492\u2013498. doi: 10.1161\/CIRCHEARTFAILURE.112.000146","journal-title":"Circ Heart Fail"},{"key":"958_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","volume":"1760","author":"J Dumic","year":"2006","unstructured":"Dumic J, Dabelic S, Flogel M (2006) Galectin-3: an open-ended story. Biochim Biophys Acta 1760:616\u2013635. doi: 10.1016\/j.bbagen.2005.12.020","journal-title":"Biochim Biophys Acta"},{"key":"958_CR23","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1017\/S1462399408000719","volume":"10","author":"RY Yang","year":"2008","unstructured":"Yang RY, Rabinovich GA, Liu FT (2008) Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 10:e17. doi: 10.1017\/S1462399408000719","journal-title":"Expert Rev Mol Med"},{"key":"958_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2353\/ajpath.2007.060906","volume":"171","author":"K Reifenberg","year":"2007","unstructured":"Reifenberg K, Lehr HA, Torzewski M et al (2007) Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am J Pathol 171:463\u2013472. doi: 10.2353\/ajpath.2007.060906","journal-title":"Am J Pathol"},{"key":"958_CR25","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.bcp.2008.02.003","volume":"75","author":"RA Thandavarayan","year":"2008","unstructured":"Thandavarayan RA, Watanabe K, Ma M et al (2008) 14-3-3 protein regulates ask1 signaling and protects against diabetic cardiomyopathy. Biochem Pharmacol 75:1797\u20131806. doi: 10.1016\/j.bcp.2008.02.003","journal-title":"Biochem Pharmacol"},{"key":"958_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/07853890.2010.538080","volume":"43","author":"RA Boer de","year":"2011","unstructured":"de Boer RA, Lok DJ, Jaarsma T et al (2011) Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 43:60\u201368. doi: 10.3109\/07853890.2010.538080","journal-title":"Ann Med"},{"key":"958_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","volume":"99","author":"DJ Lok","year":"2010","unstructured":"Lok DJ, Van Der Meer P, de la Porte PW et al (2010) Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 99:323\u2013328. doi: 10.1007\/s00392-010-0125-y","journal-title":"Clin Res Cardiol"},{"key":"958_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00392-012-0500-y","volume":"102","author":"DJ Lok","year":"2013","unstructured":"Lok DJ, Lok SI, Bruggink-Andre de la Porte PW et al (2013) Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clinical Res Cardiol 102:103\u2013110. doi: 10.1007\/s00392-012-0500-y","journal-title":"Clinical Res Cardiol"},{"key":"958_CR29","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.5603\/KP.2014.0212","volume":"72","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA et al (2014) [2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy]. Kardiol Pol 72:1054\u20131126. doi: 10.5603\/KP.2014.0212","journal-title":"Kardiol Pol"},{"key":"958_CR30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1081\/JCMR-120022267","volume":"5","author":"RJ Kim","year":"2003","unstructured":"Kim RJ, Shah DJ, Judd RM (2003) How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 5:505\u2013514","journal-title":"J Cardiovasc Magn Reson"},{"key":"958_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCIMAGING.111.971549","volume":"5","author":"P Gao","year":"2012","unstructured":"Gao P, Yee R, Gula L et al (2012) Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 5:448\u2013456. doi: 10.1161\/CIRCIMAGING.111.971549","journal-title":"Circ Cardiovasc Imaging"},{"key":"958_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11936-015-0410-1","volume":"17","author":"RB Morgan","year":"2015","unstructured":"Morgan RB, Kwong R (2015) Role of cardiac MRI in the assessment of cardiomyopathy. Curr Treat Options Cardiovasc Med 17:53. doi: 10.1007\/s11936-015-0410-1","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"958_CR33","first-page":"51","volume":"12","author":"DL Johnston","year":"1987","unstructured":"Johnston DL, Rokey R, Okada RD (1987) Nuclear magnetic resonance imaging of the cardiovascular system. Herz 12:51\u201367","journal-title":"Herz"},{"key":"958_CR34","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1161\/CIRCIMAGING.113.001217","volume":"6","author":"PG Masci","year":"2013","unstructured":"Masci PG, Schuurman R, Barison A et al (2013) Response to letters regarding article, \u201cmyocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study\u201d. Circ Cardiovasc Imaging 6:e79. doi: 10.1161\/CIRCIMAGING.113.001217","journal-title":"Circ Cardiovasc Imaging"},{"key":"958_CR35","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2147\/CIA.S88565","volume":"10","author":"X Li","year":"2015","unstructured":"Li X, Cai C, Luo R et al (2015) The usefulness of age and sex to predict all-cause mortality in patients with dilated cardiomyopathy: a single-center cohort study. Clin Interv Aging 10:1479\u20131486. doi: 10.2147\/CIA.S88565","journal-title":"Clin Interv Aging"},{"key":"958_CR36","first-page":"10488","volume":"8","author":"L Cheng","year":"2015","unstructured":"Cheng L, Zhao R, Jin Z et al (2015) Association of genetic polymorphisms on btnl2 with susceptibility to and prognosis of dilated cardiomyopathy in a chinese population. Int J Clin Exp Pathol 8:10488\u201310499","journal-title":"Int J Clin Exp Pathol"},{"key":"958_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1136\/heartjnl-2011-300814","volume":"98","author":"TF Ismail","year":"2012","unstructured":"Ismail TF, Prasad SK, Pennell DJ (2012) Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy. Heart 98:438\u2013442. doi: 10.1136\/heartjnl-2011-300814","journal-title":"Heart"},{"key":"958_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijcard.2014.12.007","volume":"181","author":"J Rodriguez-Capitan","year":"2015","unstructured":"Rodriguez-Capitan J, Garcia-Pinilla JM, Ruiz-Zamora I et al (2015) Reply to the letter \u201cprognostic value of late gadolinium enhancement in cardiomyopathy: causative risk factor or surrogate marker?\u201d Int J Cardiol 181:102\u2013103. doi: 10.1016\/j.ijcard.2014.12.007","journal-title":"Int J Cardiol"},{"key":"958_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2014.09.110","volume":"177","author":"J Rodriguez-Capitan","year":"2014","unstructured":"Rodriguez-Capitan J, Garcia-Pinilla JM, Ruiz-Zamora I et al (2014) Long-term prognostic value of late gadolinium enhancement in a cohort of patients with nonischemic dilated cardiomyopathy. Int J Cardiol 177:17\u201319. doi: 10.1016\/j.ijcard.2014.09.110","journal-title":"Int J Cardiol"},{"key":"958_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijcard.2015.02.008","volume":"184","author":"G Vergaro","year":"2015","unstructured":"Vergaro G, Del Franco A, Giannoni A et al (2015) Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy. Int J Cardiol 184:96\u2013100. doi: 10.1016\/j.ijcard.2015.02.008","journal-title":"Int J Cardiol"},{"key":"958_CR41","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","volume":"100","author":"T Ise","year":"2014","unstructured":"Ise T, Hasegawa T, Morita Y et al (2014) Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart 100:1165\u20131172. doi: 10.1136\/heartjnl-2013-305187","journal-title":"Heart"},{"key":"958_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ancard.2015.09.046","author":"E Gucuk Ipek","year":"2015","unstructured":"Gucuk Ipek E, Akin Suljevic S, Kafes H et al (2015) Evaluation of galectin-3 levels in acute coronary syndrome. Ann Cardiol Angeiol doi: 10.1016\/j.ancard.2015.09.046","journal-title":"Ann Cardiol Angeiol"},{"key":"958_CR43","doi-asserted-by":"publisher","DOI":"10.5152\/AnatolJCardiol.2015.6191","author":"S Yakar Tuluce","year":"2015","unstructured":"Yakar Tuluce S, Tuluce K, Cil Z et al (2015) Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function. Anatol J Cardiol. doi: 10.5152\/AnatolJCardiol.2015.6191","journal-title":"Anatol J Cardiol"},{"key":"958_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12756","author":"C Cuspidi","year":"2015","unstructured":"Cuspidi C, Tadic M, Sala C (2015) Galectin-3 and hypertensive heart disease. J Clin Hypertens (Greenwich). doi: 10.1111\/jch.12756","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"958_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2015.10.022","author":"B French","year":"2015","unstructured":"French B, Wang L, Ky B et al (2015) Prognostic value of galectin-3 for adverse outcomes in chronic heart failure. J Card Fail. doi: 10.1016\/j.cardfail.2015.10.022","journal-title":"J Card Fail"},{"key":"958_CR46","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10741-011-9272-0","volume":"17","author":"M Guglin","year":"2012","unstructured":"Guglin M, Verma S (2012) Right side of heart failure. Heart Fail Rev 17:511\u2013527. doi: 10.1007\/s10741-011-9272-0","journal-title":"Heart Fail Rev"},{"key":"958_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1532-429X-14-11","volume":"14","author":"BH Freed","year":"2012","unstructured":"Freed BH, Gomberg-Maitland M, Chandra S et al (2012) Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson 14:11. doi: 10.1186\/1532-429X-14-11","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-016-0958-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-016-0958-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-016-0958-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T21:28:22Z","timestamp":1498339702000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-016-0958-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,26]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["958"],"URL":"https:\/\/doi.org\/10.1007\/s10554-016-0958-1","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,26]]}}}